Design of Children's Cancer Group AML Treatment Study 2961.

Marrow samples were aspirated fresh and submitted to the AML Reference Laboratory at diagnosis, and at the end of induction, consolidation, and intensification therapies. “DCTER*” refers to dexamethasone, cytosine arabinoside, 6-thioguanine, etoposide, and rubidamycin (daunomycin). Idarubicin replaces daunomycin in “IDA-DCTER.”